TherapeuticsMD, Inc. (TXMD)
2.12
+0.01
(+0.47%)
USD |
NASDAQ |
May 22, 16:00
2.11
-0.01
(-0.47%)
After-Hours: 20:00
TherapeuticsMD EPS Diluted (Quarterly) : 0.0082 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.103M |
| Revenue (Quarterly) | 0.724M |
| Total Expenses (Quarterly) | 0.621M |
| Enterprise Value | 21.95M |
| Gross Profit Margin (Quarterly) | 55.11% |
| Profit Margin (Quarterly) | 14.23% |
| Earnings Yield | 0.73% |
| Normalized Earnings Yield | 0.9764 |